Experts estimate that over 13,000 new cervical cancer diagnoses occurred in the United States in 2025, accompanied by over 4,000 cervical cancer-related deaths. Five-year survival for patients ...

Mailed at-home self-sampling for human papillomavirus (HPV) testing increases cervical cancer screening participation in underscreened populations by almost threefold, according to a study presented ...

Cervical cancer is a devastating reality for women in Uganda and throughout Sub-Saharan Africa, ranking as one of the leading causes of cancer-related deaths in the region. It represents ...

Locoregional Thermal and Chemical Tumor Ablation: Review of Clinical Applications and Potential Opportunities for Use in Low- and Middle-Income Countries Evidence-informed recommendations generated ...

A new at-home self-collection device is taking aim at the screening gap for cervical cancer, and new research, spearheaded by a University of Colorado School of Medicine faculty member, demonstrates ...

Cervical cancer remains a major public health concern that disproportionately affects women worldwide, particularly in low- and middle-income countries. Early detection through screening ...

Add Yahoo as a preferred source to see more of our stories on Google. Now, new research finds that cervical cancer screening rates are dropping as well — and doctors aren’t happy. The study, which was ...

Professor & Director, Daffodil Centre, A Joint Venture with Cancer Council NSW, University of Sydney Karen Canfell receives funding from a range of government and non-government sources. She is ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." Cervical cancer screening is about to get a lot more convenient. That’s because the latest cervical ...

The U.S. Food and Drug Administration has approved the country’s first at-home HPV screening device. The test is designed as an alternative to the Pap smear, a procedure that detects precancerous ...

Data (patient age, HIV status, margin status, follow-up, and recurrence) from women who underwent LEEP with histologically confirmed CIN 2/3 between January 2014 and December 2015 were analyzed ...